BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 43 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $5,182,000,000 | +376.7% | 5,000,000 | +400.0% | 0.12% | +526.3% |
| Q4 2017 | $1,087,000,000 | -3.0% | 1,000,000 | 0.0% | 0.02% | +18.8% |
| Q3 2017 | $1,121,000,000 | +0.7% | 1,000,000 | 0.0% | 0.02% | -11.1% |
| Q2 2017 | $1,113,000,000 | -1.9% | 1,000,000 | 0.0% | 0.02% | -5.3% |
| Q1 2017 | $1,134,000,000 | +1.0% | 1,000,000 | 0.0% | 0.02% | -13.6% |
| Q4 2016 | $1,123,000,000 | -6.7% | 1,000,000 | 0.0% | 0.02% | +22.2% |
| Q3 2016 | $1,204,000,000 | – | 1,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MACKAY SHIELDS LLC | 37,179,000 | $41,455,000 | 2.06% |
| LINDEN ADVISORS LP | 24,592,000 | $27,360,000 | 1.20% |
| SHENKMAN CAPITAL MANAGEMENT INC | 12,025,000 | $13,415,000 | 1.15% |
| Ferox Capital Management LP | 3,465,000 | $3,889,000 | 1.09% |
| OAKTREE CAPITAL MANAGEMENT LP | 44,823,000 | $49,860,000 | 0.90% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 40,514,000 | $45,097,000 | 0.70% |
| RWC Asset Management LLP | 7,500,000 | $8,322,000 | 0.53% |
| CSS LLC/IL | 4,196,000 | $4,653,000 | 0.31% |
| SYMPHONY ASSET MANAGEMENT LLC | 2,000,000 | $2,231,000 | 0.24% |
| EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) | 3,750,000 | $4,176,000 | 0.19% |